In addition to protecting against corona, the Oxford vaccine plays an important role, a new study has revealed.

New Delhi: A new study has revealed that a vaccine developed by Oxford University and AstraZeneca not only protects people from death, but also reduces the spread of the virus. A study by researchers at Oxford University found that any corona vaccine could reduce the risk of infection.

The transmission claim is to be reduced by two-thirds

The researchers examined the people involved in the study every week to find out the effect of being infected with the virus. They found that even if someone became infected after being vaccinated, they could not spread the virus and there was a 67 percent reduction in positive swabs among those who were vaccinated. Researchers at Oxford and AstraZeneca found that the vaccine could reduce transmission by about two-thirds. However, the research results have not been reviewed by experts.

The British Health Secretary called the results encouraging

British Health Secretary Matt Hancock praised the results on Wednesday. “We now know that the Oxford vaccine also reduces transmission and will help us all get out of this epidemic,” he said. Is. ”

Scientists ’data emphasize further analysis

At the same time, warning of the limited information published in the results of this study, some scientists have warned that further analysis of the data is necessary. The chief executive of the British Society of Immunology, Dr. Doug Brown said: “This would be very welcome news, but we need more data before it can be confirmed. Therefore, it is important that even after being vaccinated, we should all continue to follow safety steps. At the societal level, one should keep a little distance from others. ”

A single dose of the vaccine is 76 percent effective

Researchers at Oxford and AstraZeneca also found that a single dose of the vaccine was 76 percent effective in preventing Covid-19. Data were measured three months after the first shot was given, not including the initial period of three weeks. These results could help in the strategy of giving first doses to more people in Britain and other countries.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *